We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

68 hedge funds and large institutions have $550M invested in Editas Medicine in 2016 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 21 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

110% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 10

39% more funds holding

Funds holding: 49 → 68 (+19)

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

12% less capital invested

Capital invested by funds: $623M → $550M (-$73.3M)

Holders
68
Holders Change
+19
Holders Change %
+38.78%
% of All Funds
1.81%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.13%
New
27
Increased
21
Reduced
10
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$5.25M
2
State Street
State Street
Massachusetts
+$2.22M
3
Northern Trust
Northern Trust
Illinois
+$1.96M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.69M
5
Renaissance Technologies
Renaissance Technologies
New York
+$752K

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$14.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$7.33M
3
WCM
Wildcat Capital Management
New York
-$6.34M
4
CC
Casdin Capital
New York
-$2.95M
5
JP Morgan Chase
JP Morgan Chase
New York
-$2.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$133M +$1.69M +50,031 +0.9%
FVFIGP
2
Flagship Ventures Fund IV General Partner
Massachusetts
$121M +$167M +4,955,316 New
PVMCV
3
Polaris Venture Management Co VI
Massachusetts
$114M – – –
Viking Global Investors
4
Viking Global Investors
Connecticut
$41.7M -$14.4M -426,122 -20%
DM
5
Deerfield Management
New York
$41.7M – – –
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$33.5M +$142K +4,220 +0.3%
Vanguard Group
7
Vanguard Group
Pennsylvania
$13M -$7.33M -217,323 -29%
Morgan Stanley
8
Morgan Stanley
New York
$7.28M +$5.25M +155,706 +109%
Capital World Investors
9
Capital World Investors
California
$7.2M – – –
AI
10
Alphabet Inc
California
$6.26M – – –
Jennison Associates
11
Jennison Associates
New York
$4.13M – – –
BFA
12
BlackRock Fund Advisors
California
$3.99M +$151K +4,466 +3%
OFM
13
Omega Fund Management
Massachusetts
$2.56M +$34 +1 +0%
State Street
14
State Street
Massachusetts
$2.45M +$2.22M +65,723 +190%
EC
15
EcoR1 Capital
California
$2.08M -$82.7K -2,452 -3%
Northern Trust
16
Northern Trust
Illinois
$1.78M +$1.96M +58,024 +387%
BIT
17
BlackRock Institutional Trust
California
$1.61M +$279K +8,265 +14%
WCM
18
Wildcat Capital Management
New York
$1.46M -$6.34M -187,968 -76%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.39M -$1.35K -40 -0.1%
Goldman Sachs
20
Goldman Sachs
New York
$1.24M -$641K -19,000 -27%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$677K +$355K +10,514 +61%
BIM
22
BlackRock Investment Management
Delaware
$646K +$36.4K +1,079 +4%
Renaissance Technologies
23
Renaissance Technologies
New York
$544K +$752K +22,304 New
TCIM
24
TIAA CREF Investment Management
New York
$494K +$177K +5,254 +35%
Charles Schwab
25
Charles Schwab
California
$473K +$357K +10,594 +121%
1
2 3 4

EDIT Hedge Fund Activity: Q2 2016 in Review

68 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2016, worth a combined $550M — down 12% from $623M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new EDIT positions and 8 closed out — a net gain of 19 holders — while 21 added to existing stakes and 10 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $5.25M. The largest seller was Viking Global Investors, cutting an estimated $14.4M.

  • 68 institutional investors held Editas Medicine (EDIT) as of Q2 2016, up from 49 in Q1 2016.
  • Funds reported $550M of Editas Medicine stock for Q2 2016, down 12% quarter-over-quarter.
  • 27 funds opened new Editas Medicine positions in Q2 2016 and 8 closed out, a net change of +19 holders.
  • The largest Editas Medicine buyer in Q2 2016 was Morgan Stanley, an estimated $5.25M added.
  • The largest Editas Medicine seller in Q2 2016 was Viking Global Investors, an estimated $14.4M sold.

Based on aggregated 13F filings for Q2 2016.